Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0263133 PHOSPHONATE DERIVATIVES AND METHODS OF USE THEREOF IN THE TREATMENT OF ALZHEIMER'S DISEASE
Benzothiazole phosphonate analogs and methods of using the same to inhibit the activity of Amyloid Binding Alcohol Dehydrogenase and in the amelioration or...
2016/0263132 INHIBITORS OF DIACYLGLYCEROL O-ACYLTRANSFERASE 1 (DGAT-1) AND USES THEREOF
The invention pertains to the use of fused bicyclo heterocyclic adducts of thiohydroxy pyridines or pyrimidines as diacylglycerol O-acyltransferase 1 (DGAT-1)...
2016/0263131 TREATMENT OF HEPATIC FIBROSIS USING AN INHIBITOR OF CBP/CATENIN
The present disclosure relates generally to alpha-helix mimetic structures and specifically to alpha-helix mimetic structures that are inhibitors of...
2016/0263130 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LIVER DISEASES, CONTAINING PLASMALOGEN PRECURSOR,...
The present invention relates to a pharmaceutical composition for preventing or treating liver diseases, containing a plasmalogen precursor, plasmalogen, or a...
2016/0263129 Controlled Release Doxycycline
The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline...
2016/0263128 USE OF 25-HYDROXY-VITAMIN D3 TO AFFECT HUMAN MUSCLE PHYSIOLOGY
We disclose the use of 25-OH D3 (calcifediol) to increase muscle strength, muscle function, or both. Vitamin D3 (cholecalciferol) may optionally be used...
2016/0263127 17 Alpha, 21-Dihydroxypregnene Esters as Antiandrogenic Agents
The present application provides 17 and/or 21 esters of 17.alpha.,21-Dihydroxypregna-4,9(11)-diene-3,20-dione and 17.alpha.,21 ...
2016/0263126 COMPOSITIONS AND THERAPEUTIC METHODS FOR THE TREATMENT OF COMPLEMENT-ASSOCIATED DISEASES
The invention comprises methods of modulating the complement cascade in a mammal and for treating and/or preventing diseases and disorders associated with the...
2016/0263125 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF
Amino, amido, and heterocyclic compounds are disclosed. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and...
2016/0263124 Compounds for the Treatment of Diabetes and Disease Complications Arising from Same
The present invention is directed to use of a series of tri-aryl compounds and compositions comprising the same for the treatment of diabetes and disease...
2016/0263123 MESOPOROUS DOSAGE FORMS FOR POORLY SOLUBLE DRUGS
The present invention is directed to a new pharmaceutical dosage form comprising mesoporous particles loaded with a poorly soluble active pharmaceutical...
2016/0263122 NOVEL COMPOUNDS
The present invention relates to substituted N-(phenyl-heteroaryl)-3-acetylamino-benzamides and N-[3-(acetylamino)phenyl]-phenyl-heteroaryl-carboxamides of...
2016/0263121 STABLE POWDER FORMULATION CONTAINING AN ANTICHOLINGERIC AGENT
##STR00001## A spray-dried powder formulation comprising particles that contain the following components i) to iii): i) anticholinergic agents, in particular ...
2016/0263120 TREATMENT OF ERECTILE DYSFUNCTION AND OTHER INDICATIONS
The present invention generally relates to the transdermal delivery of various compounds. In some aspects, transdermal delivery may be facilitated by the use...
2016/0263119 TREATMENT OF ERECTILE DYSFUNCTION AND OTHER INDICATIONS
The present invention generally relates to the transdermal delivery of various compounds. In some aspects, transdermal delivery may be facilitated by the use...
2016/0263118 Inhibitors of Phosphodiesterase Type 5A for Treating or Preventing Muscle Disease or the Symptoms Thereof in a...
Disclosed are pharmaceutical compositions and methods for treating or preventing muscle diseases or the symptoms thereof. The compositions typically include...
2016/0263117 COMPOSITIONS AND METHODS FOR CARDIOVASCULAR DISEASE
The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to reduce circulating levels of ApoB-100 or LDL. These...
2016/0263116 COMBINATIONS
The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method...
2016/0263115 Novel Pyrimidinyl-DiazoSpiro Compounds
The invention relates to spiro derivatives, to the use of said derivatives intreating diseases and conditions mediated by modulation of voltage-gated sodium...
2016/0263114 COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGRADATION
The present disclosure relates to compositions and methods for treating retinal damage and/or retinal degradation. More specifically, this disclosure relates...
2016/0263113 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or...
2016/0263112 SUBSTITUTED PYRIMIDINES FOR TREATMENT OF ACUTE COUGH, CHRONIC COUGH AND URGE TO COUGH
Methods for treating cough, chronic cough and urges to cough associated with respiratory diseases with a P2X3 and/or a P2X2/3 receptor antagonist, the methods...
2016/0263111 ARIPIPRAZOLE FORMULATIONS HAVING INCREASED INJECTION SPEEDS
The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of ...
2016/0263110 USE OF MASITINIB FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
A treatment of patients afflicted with Amyotrophic Lateral Sclerosis (ALS), wherein the patients are treated with a tyrosine kinase inhibitor, mast cell...
2016/0263109 P13K INHIBITOR FOR TREATMENT OF RESPIRATORY DISEASE
The present invention is directed to compounds and pharmaceutically acceptable salts thereof which are inhibitors of the activity or function of the...
2016/0263108 NRF2 INHIBITORS AND COMPOSITIONS FOR TREATING MYCOBACTERIAL INFECTIONS
Provided herein are methods, compositions, and kits for Nr2 inhibitors and their use in treatment of mycobacterial infection and in combination therapy with...
2016/0263107 Treating Pain In Patients With Hepatic Impairment
An extended release composition for an analgesic active pharmaceutical ingredient which may be an opioid, preferably hydrocodone as the only active ingredient....
2016/0263106 ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM
Abuse-resistant, controlled release opioid tablets are a combination containing an opioid antagonist such as naloxone at a level above that needed to suppress...
2016/0263105 MULTIDRUG INFUSION FOR PAIN CONTROL
The present invention relates to a formulation comprising an opioid, a Na channel blocker, an alpha2-receptor agonist, an opioid mu or delta receptor...
2016/0263104 COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS
The present invention relates to compositions and methods for the treatment of the Charcot-Marie-Tooth disease and related disorders.
2016/0263103 PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGONIST AND IRRITANT AGENT
Disclosed in certain embodiments is an oral dosage form comprising: a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and an...
2016/0263102 PHARMACEUTICAL COMPOSITION OF BUPROPION AND NALTREXONE
A pharmaceutical composition of bupropion or salts thereof and naltrexone or salts thereof is provided. The composition comprises bupropion and naltrexone in a...
2016/0263101 8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS
8'-Hydroxy-Dihydroergotamine (8'-OH DHE) medicinal compounds, compositions, and dosage forms containing such compositions are provided. Also provided herein...
2016/0263100 COMPOSITIONS AND METHODS FOR INCREASING THE METABOLIC LIFETIME OF DEXTROMETHORPHAN AND RELATED PHARMACODYNAMIC...
This disclosure relates to methods administering various compounds in conjunction with dextromethorphan to a human being. Dosage forms, drug delivery systems,...
2016/0263099 COMPOSITIONS AND METHODS FOR INCREASING THE METABOLIC LIFETIME OF DEXTROMETHORPHAN AND RELATED PHARMACODYNAMIC...
This disclosure relates to methods administering various compounds in conjunction with dextromethorphan to a human being. Dosage forms, drug delivery systems,...
2016/0263098 METHODS FOR THE TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE AND/OR LIPODYSTROPHY
The present invention relates to methods for treating a disease associated with insulin resistance selected from a nonalcoholic fatty liver disease (NAFLD) and...
2016/0263097 APIXABAN LIQUID FORMULATIONS
Apixaban liquid formulation is provided. Also provided is a method of administering an apixaban liquid formulation.
2016/0263096 USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY
The present invention concerns a method for modulating the enzymatic activity of an enzyme, wherein said enzyme interacts with BMP, said method comprising the...
2016/0263095 METHODS FOR TREATING NEWLY DIAGNOSED MULTIPLE MYELOMA WITH ...
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are...
2016/0263094 Pantoprazole Sodium Composition Lyophilized Powder for Injection
The invention provides pantoprazole sodium composition lyophilized powder for injection, and relates to the technical field of medicines and manufacturing of...
2016/0263093 S1P modulating agents
Compounds of formula (I) or (II) can modulate the activity of S1P receptors.
2016/0263092 THERAPEUTIC USES OF BERBERINE FORMULATIONS
Uses of pharmaceutical compositions comprising berberine for treatment of dermatologic toxicities and other skin disorders.
2016/0263091 ACLIDINIUM FOR USE IN IMPROVING THE QUALITY OF SLEEP IN RESPIRATORY PATIENTS
The present disclosure provides aclidinium or any of its stereoisomers or mixture of stereoisomers, or a pharmaceutically acceptable salt or solvate thereof,...
2016/0263090 ANTI-FIBROTIC PYRIDINONES
Disclosed are pyridinone compounds, method for preparing these compounds, and methods for treating fibrotic disorders.
2016/0263089 SECURININE AND NORSECURININE ANALOGUE COMPOUNDS FOR THE TREATMENT OF MYELOID DISORDERS
The present application relates to securinine or norsecurinine analogues that, when administered to immature myeloid cells, promote differentiation of these...
2016/0263088 Methods and Compositions for Treating Chronic Pain
Certain embodiments are directed to methods of treating pain, e.g., chronic or neuropathic pain, comprising administering an effective amount of an EPAC...
2016/0263087 NOVEL 4-(INDOL-3-YL)-PYRAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
4-(Indol-3-yl)-pyrazole derivative compounds of Formula I or pharmaceutically acceptable enantiomers, salts or solvates thereof are provided. Further provided...
2016/0263086 METHODS AND COMPOSITIONS FOR TREATING CANCER
Methods and compositions provided herein relate to the treatment of cancer. In some embodiments, the compositions have utility in the treatment of cancers...
2016/0263085 SUPER-OXIDE DISMUTASE MIMETICS
The present invention relates to compounds which are effective as catalysts for dismutating superoxide and, more particularly, the manganese or iron complexes...
2016/0263084 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS
The present invention discloses compounds according to Formula I: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, L, and the subscript m are as defined herein....
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.